On Friday, MBX Biosciences Inc (NASDAQ: MBX) opened higher 5.16% from the last session, before settling in for the closing price of $12.4. Price fluctuations for MBX have ranged from $4.81 to $27.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 52.89% at the time writing. With a float of $14.84 million, this company’s outstanding shares have now reached $33.42 million.
In an organization with 43 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MBX Biosciences Inc (MBX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of MBX Biosciences Inc is 55.59%, while institutional ownership is 54.40%. The most recent insider transaction that took place on Apr 08 ’25, was worth 45,312. In this transaction Director of this company bought 7,693 shares at a rate of $5.89, taking the stock ownership to the 24,329 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Director bought 143,170 for $10.84, making the entire transaction worth $1,551,963. This insider now owns 3,255,000 shares in total.
MBX Biosciences Inc (MBX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 52.89% per share during the next fiscal year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
Check out the current performance indicators for MBX Biosciences Inc (MBX). In the past quarter, the stock posted a quick ratio of 23.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.20, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.68 in one year’s time.
Technical Analysis of MBX Biosciences Inc (MBX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.4 million. That was better than the volume of 0.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.56%.
During the past 100 days, MBX Biosciences Inc’s (MBX) raw stochastic average was set at 86.41%, which indicates a significant increase from 76.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.17 in the past 14 days, which was higher than the 1.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.63, while its 200-day Moving Average is $14.37. However, in the short run, MBX Biosciences Inc’s stock first resistance to watch stands at $13.78. Second resistance stands at $14.52. The third major resistance level sits at $15.51. If the price goes on to break the first support level at $12.05, it is likely to go to the next support level at $11.06. Assuming the price breaks the second support level, the third support level stands at $10.32.
MBX Biosciences Inc (NASDAQ: MBX) Key Stats
There are currently 33,424K shares outstanding in the company with a market cap of 435.85 million. Presently, the company’s annual sales total 0 K according to its annual income of -61,920 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -23,880 K.
